Found: 5
Select item for more details and to access through your institution.
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01022-w
- By:
- Publication type:
- Article
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5443, doi. 10.3390/cancers15225443
- By:
- Publication type:
- Article
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4334, doi. 10.3390/cancers15174334
- By:
- Publication type:
- Article
Development of an instrument to analyze organizational characteristics in multidisciplinary care pathways; the case of colorectal cancer.
- Published in:
- BMC Research Notes, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13104-015-1084-1
- By:
- Publication type:
- Article
Off-Label Use of Drugs in Pain Medicine and Palliative Care: An Algorithm for the Assessment of its Safe and Legal Prescription.
- Published in:
- Pain Practice, 2008, v. 8, n. 3, p. 157, doi. 10.1111/j.1533-2500.2008.00189.x
- By:
- Publication type:
- Article